241 related articles for article (PubMed ID: 36521904)
21. Association of Serum Ferritin Levels and Methylprednisolone Treatment With Outcomes in Nonintubated Patients With Severe COVID-19 Pneumonia.
Papamanoli A; Kalogeropoulos AP; Hotelling J; Yoo J; Grewal P; Predun W; Jacob RP; Cao K; Marcos LA; Skopicki HA
JAMA Netw Open; 2021 Oct; 4(10):e2127172. PubMed ID: 34605919
[TBL] [Abstract][Full Text] [Related]
22. Secretory Phospholipase A2 and Interleukin-6 Levels as Predictive Markers of the Severity and Outcome of Patients with COVID-19 Infections.
Urazov S; Chernov A; Popov O; Klenkova N; Sushentseva N; Polkovnikova I; Apalko S; Kislyuk K; Pavlovich D; Ivanov A; Shcherbak S
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982611
[TBL] [Abstract][Full Text] [Related]
23. Presepsin as a Novel Biomarker in predicting In-hospital Mortality in Patients With COVID-19 Pneumonia.
Assal HH; Abdelrahman SM; Abdelbasset MA; Abdelaziz M; Sabry IM; Shaban MM
Int J Infect Dis; 2022 May; 118():155-163. PubMed ID: 35248717
[TBL] [Abstract][Full Text] [Related]
24. Interleukin-6, procalcitonin and neutrophil-to-lymphocyte ratio: Potential immune-inflammatory parameters to identify severe and fatal forms of COVID-19.
Sayah W; Berkane I; Guermache I; Sabri M; Lakhal FZ; Yasmine Rahali S; Djidjeli A; Lamara Mahammed L; Merah F; Belaid B; Berkani L; Lazli NZ; Kheddouci L; Kadi A; Ouali M; Khellafi R; Mekideche D; Kheliouen A; Hamidi RM; Ayoub S; Raaf NB; Derrar F; Gharnaout M; Allam I; Djidjik R
Cytokine; 2021 May; 141():155428. PubMed ID: 33550165
[TBL] [Abstract][Full Text] [Related]
25. Clinical and Immune Features of Hospitalized Pediatric Patients With Coronavirus Disease 2019 (COVID-19) in Wuhan, China.
Wu H; Zhu H; Yuan C; Yao C; Luo W; Shen X; Wang J; Shao J; Xiang Y
JAMA Netw Open; 2020 Jun; 3(6):e2010895. PubMed ID: 32492165
[TBL] [Abstract][Full Text] [Related]
26. A randomized open-label trial to evaluate the efficacy and safety of triple therapy with aspirin, atorvastatin, and nicorandil in hospitalised patients with SARS Cov-2 infection: A structured summary of a study protocol for a randomized controlled trial.
Sharma A; Sharma C; Raina S; Singh B; Dadhwal DS; Dogra V; Gupta S; Bhandari S; Sood V
Trials; 2021 Jul; 22(1):451. PubMed ID: 34266452
[TBL] [Abstract][Full Text] [Related]
27. 'Immune-inflammatory markers & clinical characteristics for outcomes in hospitalized SARS-CoV-2 infected patients of Pakistan: a retrospective analysis'.
Khalid A; Aqeel RF; Nawaz A; Ahmad J; Fatima ST; Shahid S; Rao AA; Aktas G; Ijaz S; Shehryar M
Hematology; 2023 Dec; 28(1):2199629. PubMed ID: 37408482
[TBL] [Abstract][Full Text] [Related]
28. Laboratory biomarker predictors for disease progression and outcome among Egyptian COVID-19 patients.
Fathalla LA; Kamal LM; Salaheldin O; Khalil MA; Kamel MM; Fahim HH; Abdel-Moneim YA; Abdulhakim JA; Abdel-Moneim AS; El-Meligui YM
Int J Immunopathol Pharmacol; 2022; 36():3946320221096207. PubMed ID: 35622504
[TBL] [Abstract][Full Text] [Related]
29. Iron metabolism and lymphocyte characterisation during Covid-19 infection in ICU patients: an observational cohort study.
Bolondi G; Russo E; Gamberini E; Circelli A; Meca MCC; Brogi E; Viola L; Bissoni L; Poletti V; Agnoletti V
World J Emerg Surg; 2020 Jun; 15(1):41. PubMed ID: 32605582
[TBL] [Abstract][Full Text] [Related]
30. Clinical characteristics, treatment outcomes and factors associated with severe illness in 813 COVID-19 patients admitted in a tertiary care hospital of eastern India.
Rai DK; H A; Lohani P; Pandey S; Vardhan H
Adv Respir Med; 2022; 90(3):193-201. PubMed ID: 35731112
[TBL] [Abstract][Full Text] [Related]
31. Treatment of COVID-19 pneumonia with glucocorticoids (CORTIVID): a structured summary of a study protocol for a randomised controlled trial.
Les Bujanda I; Loureiro-Amigo J; Bastons FC; Guerra IE; Sánchez JA; Murgadella-Sancho A; Rey RG; López JL; Álvarez JS
Trials; 2021 Jan; 22(1):43. PubMed ID: 33430891
[TBL] [Abstract][Full Text] [Related]
32. Mortality in Patients of COVID-19 Infection: Biochemical Markers and its Cut-off Values for Predicting Outcome.
Yousaf MN; Sarwar S; Tarique S; Ahmed M; Tahir H
J Coll Physicians Surg Pak; 2022 Jan; 32(1):37-41. PubMed ID: 34983145
[TBL] [Abstract][Full Text] [Related]
33. First wave of COVID-19 hospital admissions in Denmark: a Nationwide population-based cohort study.
Holler JG; Eriksson R; Jensen TØ; van Wijhe M; Fischer TK; Søgaard OS; Israelsen SB; Mohey R; Fabricius T; Jøhnk F; Wiese L; Johnsen S; Søborg C; Nielsen H; Kirk O; Madsen BL; Harboe ZB
BMC Infect Dis; 2021 Jan; 21(1):39. PubMed ID: 33421989
[TBL] [Abstract][Full Text] [Related]
34. Early increase of serum ferritin among COVID-19 patients is associated with need of invasive mechanical ventilation and with in-hospital death.
Ramonfaur D; Aguirre-García GM; Diaz-Garza CA; Torre-Amione G; Sanchez-Nava VM; Lara-Medrano R; Ramírez-Elizondo MT; Esparza-Sandoval AC; Ortega-Hernández FJ; Martínez-Reséndez MF
Infect Dis (Lond); 2022 Nov; 54(11):810-818. PubMed ID: 35854671
[TBL] [Abstract][Full Text] [Related]
35. Interpretation of Hematological, Biochemical, and Immunological Findings of COVID-19 Disease: Biomarkers Associated with Severity and Mortality.
Ghazanfari T; Salehi MR; Namaki S; Arabkheradmand J; Rostamian A; Rajabnia Chenary M; Ghaffarpour S; Kaboudanian Ardestani S; Edalatifard M; Naghizadeh MM; Mohammadi S; Mahloujirad M; Izadi A; Ghanaati H; Beigmohammadi MT; Vodjgani M; Mohammad Shirazi B; Mirsharif ES; Abdollahi A; Mohammadi M; Emadi Kouchak H; Dehghan Manshadi SA; Zamani MS; Mahmoodi Aliabadi M; Jamali D; Khajavirad N; Mohseni Majd AM; Nasiri Z; Faghihzadeh S
Iran J Allergy Asthma Immunol; 2021 Feb; 20(1):46-66. PubMed ID: 33639632
[TBL] [Abstract][Full Text] [Related]
36. The predictive and prognostic role of hematologic and biochemical parameters in the emergency department among coronavirus disease 2019 patients.
Huang CY; Tsai HW; Liu CY; Liu TH; Huang HL; Chang CC; Chen WC; Sun JT
Chin J Physiol; 2021; 64(6):306-311. PubMed ID: 34975124
[TBL] [Abstract][Full Text] [Related]
37. Norwegian Coronavirus Disease 2019 (NO COVID-19) Pragmatic Open label Study to assess early use of hydroxychloroquine sulphate in moderately severe hospitalised patients with coronavirus disease 2019: A structured summary of a study protocol for a randomised controlled trial.
Lyngbakken MN; Berdal JE; Eskesen A; Kvale D; Olsen IC; Rangberg A; Jonassen CM; Omland T; Røsjø H; Dalgard O
Trials; 2020 Jun; 21(1):485. PubMed ID: 32503662
[TBL] [Abstract][Full Text] [Related]
38. Clinical characteristics and outcomes of invasively ventilated patients with COVID-19 in Argentina (SATICOVID): a prospective, multicentre cohort study.
Estenssoro E; Loudet CI; Ríos FG; Kanoore Edul VS; Plotnikow G; Andrian M; Romero I; Piezny D; Bezzi M; Mandich V; Groer C; Torres S; Orlandi C; Rubatto Birri PN; Valenti MF; Cunto E; Sáenz MG; Tiribelli N; Aphalo V; Reina R; Dubin A;
Lancet Respir Med; 2021 Sep; 9(9):989-998. PubMed ID: 34224674
[TBL] [Abstract][Full Text] [Related]
39. Longitudinal changes in inflammatory biomarkers among patients with COVID-19: A nationwide study in Iceland.
Oskarsdottir T; Sigurdsson MI; Palsson R; Eythorsson E
Acta Anaesthesiol Scand; 2022 Sep; 66(8):969-977. PubMed ID: 35748857
[TBL] [Abstract][Full Text] [Related]
40. Clinical and Epidemiological Features of SARS-CoV-2 Patients in SARI Ward of a Tertiary Care Centre in New Delhi.
Aggarwal A; Shrivastava A; Kumar A; Ali A
J Assoc Physicians India; 2020 Jul; 68(7):19-26. PubMed ID: 32602676
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
